YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
3.240
-0.460 (-12.43%)
At close: Sep 17, 2026, 4:00 PM EDT
3.190
-0.050 (-1.54%)
After-hours: Sep 17, 2026, 7:30 PM EDT
YD Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 2.66 | 6.01 | 3.13 | 0.09 | 0.03 |
Cash & Short-Term Investments | 2.66 | 6.01 | 3.13 | 0.09 | 0.03 |
Cash Growth | - | 91.80% | 3496.29% | 188.96% | - |
Accounts Receivable | 0.22 | 0.46 | 0.1 | 0.1 | 0.04 |
Other Receivables | 0.03 | - | 0.16 | 0 | 0 |
Receivables | 0.26 | 0.46 | 0.26 | 0.1 | 0.04 |
Inventory | 1.89 | 1.88 | 0.04 | 0.07 | 0.04 |
Prepaid Expenses | 0.78 | 1.32 | 0.03 | 0 | 0 |
Other Current Assets | - | - | 0.01 | 0.01 | 0.02 |
Total Current Assets | 5.59 | 9.67 | 3.47 | 0.27 | 0.13 |
Property, Plant & Equipment | 0.06 | 0.07 | 0.09 | 0.01 | 0.06 |
Long-Term Investments | - | - | - | 0.01 | 0.01 |
Other Intangible Assets | 2.47 | 2.61 | 2.68 | - | - |
Long-Term Deferred Tax Assets | - | - | - | 0.02 | 0.03 |
Long-Term Deferred Charges | - | - | 0.63 | - | - |
Other Long-Term Assets | 1.94 | 1.43 | - | - | - |
Total Assets | 10.06 | 13.78 | 6.86 | 0.32 | 0.23 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 0.37 | 0.41 | 0.03 | 0.02 | 0.01 |
Accrued Expenses | 0.33 | 0.44 | 0.22 | 0.02 | 0.01 |
Current Portion of Long-Term Debt | - | - | - | 0.03 | 0.03 |
Current Portion of Leases | 0.01 | 0.01 | 0.02 | 0.01 | 0.04 |
Other Current Liabilities | 0.36 | 0.79 | - | 0.22 | 0.07 |
Total Current Liabilities | 1.07 | 1.64 | 0.26 | 0.3 | 0.17 |
Long-Term Debt | - | - | - | - | 0.04 |
Long-Term Leases | - | - | 0.01 | - | 0.01 |
Long-Term Deferred Tax Liabilities | - | - | 0 | - | - |
Other Long-Term Liabilities | 4.52 | 14.99 | 0 | - | - |
Total Liabilities | 5.59 | 16.64 | 0.27 | 0.3 | 0.22 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 0.01 | 0.01 | 0.14 | 0.11 | 0.11 |
Additional Paid-In Capital | 7.86 | 7.16 | 8.33 | 0.39 | 0.39 |
Retained Earnings | -3.54 | -10.24 | -1.93 | -0.52 | -0.53 |
Comprehensive Income & Other | 0.14 | 0.21 | 0.05 | 0.05 | 0.05 |
Shareholders' Equity | 4.47 | -2.86 | 6.59 | 0.02 | 0.01 |
Total Liabilities & Equity | 10.06 | 13.78 | 6.86 | 0.32 | 0.23 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 0.01 | 0.01 | 0.02 | 0.05 | 0.12 |
Net Cash (Debt) | 2.66 | 6 | 3.11 | 0.04 | -0.09 |
Net Cash Growth | - | 92.95% | 7769.12% | - | - |
Net Cash Per Share | 0.04 | 0.09 | 2.84 | 0.04 | - |
Filing Date Shares Outstanding | 70.84 | 70.79 | 1.44 | 1.05 | - |
Total Common Shares Outstanding | 70.84 | 70.79 | 1.44 | 1.05 | - |
Working Capital | 4.52 | 8.03 | 3.2 | -0.03 | -0.04 |
Book Value Per Share | 0.06 | -0.04 | 4.57 | 0.02 | - |
Tangible Book Value | 2 | -5.47 | 3.91 | 0.02 | 0.01 |
Tangible Book Value Per Share | 0.03 | -0.08 | 2.71 | 0.02 | - |
Machinery | - | - | 0.08 | 0.01 | 0.04 |
Leasehold Improvements | - | - | - | - | 0.05 |